openPR Logo
Press release

Targeted Therapy Market is Fueled by Precision Medicine Oncology Growth and Biomarker-Based Drug Development|Key Players: F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., AstraZeneca

07-15-2025 02:50 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Targeted Therapy Market

Targeted Therapy Market

Targeted Therapy Market reached US$ 79.18 billion in 2024 and is expected to reach US$ 147.16 billion by 2033, growing at a CAGR of 7.2% during the forecast period 2025-2033.

The latest Targeted Therapy Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/targeted-therapy-market?ophp

Targeted therapies are precision medicines that block the growth of cancer by interfering with specific molecules involved in tumor progression. The market is growing significantly due to rising cancer incidence, expansion of companion diagnostics, and continued breakthroughs in monoclonal antibodies, kinase inhibitors, and biomarker-driven drug development.

Targeted Therapy Market Competitors Overview:

F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., AstraZeneca, Eisai Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company., Incyte, Eli Lilly and Company, and Exelixis, Inc., among others.

Important Industry Updates of 2024 and 2025:

In May 2025, the U.S. Food and Drug Administration (FDA) provided accelerated approval for EMRELIS (telisotuzumab vedotin-tllv) developed by AbbVie, for the treatment of adult patients with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression (OE) who have received a prior systemic therapy.

✅ In March 2025, Genmab A/S announced that the Japan Ministry of Health, Labour and Welfare approved TIVDAK (tisotumab vedotin) for the treatment of advanced or recurrent cervical cancer that has progressed on or after cancer chemotherapy. TIVDAK is an antibody drug conjugate that received first approval in Japan for cervical cancer patients.

✅ In October 2024, Genentech a member of the Roche Group, announced that the U.S. FDA approved Itovebi (inavolisib) a targeted therapy, in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer.

Targeted Therapy Market Segments Overview:

∎ By Type (Monoclonal Antibodies, Small Molecules)
∎ By Indication (Leukemia, Breast Cancer, Lung Cancer, GI Cancers, Melanoma, Others)
∎ By Route of Administration (Oral, Parenteral)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/targeted-therapy-market?ophp

Methodology and Scope:

This Targeted Therapy Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Targeted Therapy Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=targeted-therapy-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Targeted Therapy market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Targeted Therapy market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Targeted Therapy Market is Fueled by Precision Medicine Oncology Growth and Biomarker-Based Drug Development|Key Players: F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., AstraZeneca here

News-ID: 4104991 • Views:

More Releases from DataM intelligence 4 Market Research LLP

MicroRNA Market Size to Hit USD 4,960 Million with a 13.2% CAGR by 2033, Report by DataM Intelligence
MicroRNA Market Size to Hit USD 4,960 Million with a 13.2% CAGR by 2033, Report …
The microRNA (miRNA) market is gaining strong traction as research uncovers the critical role of miRNAs in regulating gene expression, disease progression, and therapeutic development. MicroRNAs are small, non-coding RNA molecules that act as master regulators of cellular processes such as differentiation, proliferation, apoptosis, and metabolism. Their unique ability to influence multiple genes makes them attractive for biomarker discovery, diagnostics, and therapeutic development. Increasing prevalence of cancer, cardiovascular disorders, and
Precision Potentiometers Market 2025 | Growth Trends, Key Players & Investment Opportunities
Precision Potentiometers Market 2025 | Growth Trends, Key Players & Investment O …
Market Size and Growth Global Precision Potentiometers Market reached US$ 1.40 billion in 2023 and is expected to reach US$ 2.30 billion by 2031, growing with a CAGR of 6.3% during the forecast period 2024-2031, according to DataM Intelligence report. Precision Potentiometers Market report, published by DataM Intelligence has released its latest in-depth analysis on the global Precision Potentiometers Market, delivering a detailed overview of regional growth patterns, market segmentation, CAGR, and
Capillary Electrophoresis Market Major Factors Fueling Demand in Genomics, Diagnostics, and Pharma
Capillary Electrophoresis Market Major Factors Fueling Demand in Genomics, Diagn …
The capillary electrophoresis (CE) market is witnessing steady growth as demand rises for efficient, accurate, and cost-effective analytical techniques in life sciences, clinical diagnostics, food safety, and pharmaceutical quality control. Capillary electrophoresis separates ionic molecules based on their electrophoretic mobility using an applied voltage, making it a widely used technique for DNA analysis, protein characterization, drug purity testing, and biomarker discovery. Its high-resolution separation, small sample volume requirement, and minimal
Shipbuilding Anti-Vibration Market Outlook 2025 | Market Trends, Expansion & Leading Companies
Shipbuilding Anti-Vibration Market Outlook 2025 | Market Trends, Expansion & Lea …
Market Size and Growth Shipbuilding Anti-Vibration Market is expected to grow at a CAGR of 4.80% during the forecast period (2024-2031). Shipbuilding Anti-Vibration Market report, published by DataM Intelligence has released its latest in-depth analysis on the global Shipbuilding Anti-Vibration Market, delivering a detailed overview of regional growth patterns, market segmentation, CAGR, and financial performance among leading industry players. The report offers readers a clear snapshot of the current market

All 5 Releases


More Releases for Targeted

Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights: • Global Targeted Alpha Therapy Market Insight By Region • Approved Targeted Alpha Therapy Dosage & Pricing Insight • Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs • Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase • Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication • Targeted Alpha Therapy Proprietary Technology Platform Insights By
Dark Truth Behind Targeted Violence
Intimidation and cyberbullying public bullying the (target)victims selected into committing the violent criminal acts if the victims mentality was broken. The perpetrators are small fraud groups organizing misinformation with false profiles for the public to participate with public bullying while the groups stalk the victim. San Diego California 2021-2024 plot failed federal agents on standby monitoring the targets failed at there duties of integrity while presidential elections push towards Nov 5 San
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes. One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in
Targeted Email Leads: Pioneering a New Era in Email Marketing with High-Quality, …
GREENSBORO, NC - 15 August 2024 - In the rapidly evolving digital landscape, one company is setting new standards in email marketing. Targeted Email Leads, a trailblazer in the provision of precision-targeted email lists, is offering meticulously cleaned and verified lists that cater to a wide range of applications, from B2B communications to consumer engagement and interest groups. What sets Targeted Email Leads apart is their rigorous verification process. Each
Tetravalent Antibody as Cancer Targeted Therapy
The advent of tetravalent antibodies marks a significant breakthrough in cancer targeted therapy, offering a sophisticated approach to tackling the complex and heterogeneous nature of tumors. These antibodies, engineered to bind to four distinct antigens or epitopes simultaneously, provide enhanced specificity and efficacy, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Cancer is a multifaceted disease characterized by diverse cell populations within a
Targeted Advertising Solutions Market - Rising Demand from the Providers of Targ …
The rising popularity of digital channels such as mobile and online for media and entertainment, and communications, coupled with their capability to identify and benefit from tracking customer behavior accurately, have created major interest and increasing investments by advertisers on targeted advertising. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47862 Organizations making an entry into the advertising value network need to effectively educate, engage, and create alertness to the advantages of targeted